Trademark Overview
On Monday, June 30, 2025, a trademark application was filed for HAEBRII with the United States Patent and Trademark Office. The USPTO has given the HAEBRII trademark a serial number of 99260329. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, June 30, 2025. This trademark is owned by Pharvaris GmbH. The HAEBRII trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations for the treatment and prevention of rare and orphan diseases and disorders; pharmaceutical preparations for the treatment and prevention of hematological diseases and disorders; pharmaceutical preparations for the treatment and prevention of inflammatory diseases and disorders; pharmaceutical preparations for the treatment and prevention of genetic diseases and disorders; pharmaceutical preparations for the treatment and prevention of hereditary angioedema (HAE); pharmaceutical preparations for the treatment and prevention of bradykinin mediated angioedema; pharmaceutical preparations for the treatment and prevention of acquired angioedema
Providing medical information to healthcare providers and patients relating to hematological, inflammatory, genetic, and rare diseases and disorders; providing medical information, namely, providing healthcare providers and patients with information, assistance and support regarding clinical aspects, disease management resources, and access to pharmaceuticals for the treatment and prevention of hereditary angioedema